pilocarpine has been researched along with Basal Ganglia Diseases in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 7.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| "We studied the relationship between the efficiency of muscarinic receptor antagonists in preventing haloperidol-induced catatonia and their activity in tests for the interaction of ligands with various subtypes of muscarinic receptors (M1-M4) in rats." | 3.72 | Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats. ( Beliaev, VA; Dagaev, SG; Dolgo-Saburov, VB; Filko, OA; Khrabrova, AV; Kosmachev, AB; Kubarskaya, LG; Libman, NM; Podosinovikova, NP; Sanotskii, VI, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagaev, SG | 1 |
| Kosmachev, AB | 1 |
| Filko, OA | 1 |
| Kubarskaya, LG | 1 |
| Khrabrova, AV | 1 |
| Beliaev, VA | 1 |
| Podosinovikova, NP | 1 |
| Libman, NM | 1 |
| Sanotskii, VI | 1 |
| Dolgo-Saburov, VB | 1 |
| Fregnan, GB | 1 |
| Vidali, M | 1 |
2 other studies available for pilocarpine and Basal Ganglia Diseases
| Article | Year |
|---|---|
Effect of M4-cholinoceptor blockade on haloperidol-produced catatonic syndrome in rats.
Topics: Animals; Basal Ganglia Diseases; Catatonia; Haloperidol; Kinetics; Ligands; Male; Models, Biological | 2004 |
Appearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS active drugs.
Topics: Animals; Antipsychotic Agents; Atropine; Autonomic Agents; Basal Ganglia Diseases; Central Nervous S | 1982 |